Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polyps 2Hyperplasia 2Colorectal Neoplasms 2Weight Loss 1Psoriasis 1Osteoarthritis 1Colitis, Ulcerative 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Cancer Cachexia 1Cachexia 1Breast Neoplasms 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Anorexia 1Adenomatous Polyps 1Adenomatous Polyposis Coli 1

Interventions

acetaminophen, codeine drug combination 1Vitamin D 1Syringes 1Oxycodone 1Nutrition Assessment 1Naloxone 1Inosine Monophosphate 1Injections, Intra-Articular 1Fish Oils 1Fatty Acids, Omega-3 1Eicosapentaenoic Acid 1Docosahexaenoic Acids 1Cholecalciferol 1Arthroplasty, Replacement, Shoulder 1Arthroplasty, Replacement, Elbow 1Adalimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Osteoarthritis × Eicosapentaenoic Acid × Clear all
NCT01351805 2025-12-03

VITAL

Brigham and Women's Hospital

Phase NA Completed
25,871 enrolled 15 charts

Arthritis, Rheumatoid, Autoimmune Diseases, Osteoarthritis, Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡